Rates of complete diagnostic testing for patients with acute myeloid leukemia. (26th January 2015)

• Record Type: Journal Article
• Authors: Lin, Tara L.; Williams, Travis; He, Jianghua; Aljitawi, Omar S.; Ganguly, Siddhartha; Abhyankar, Sunil; Fleming, Allan; Male, Heather; McGuirk, Joseph P.
• Is Part Of: Cancer medicine. Volume 4:Number 4(2015:Apr.)
• Page Start: 519
• Page End: 522
• Publication Date: 2015-01-26
• Subjects: 616.994005
• DOI: 10.1002/cam4.406
• Languages: English
• ISSNs: 2045-7634

Abstract

<abstract abstract-type="graphical" xml:lang="en" id="cam4406-abs-0002"> <title> <x xml:space="preserve">Abstract</x> </title> <p>In addition to cytogenetics, additional molecular markers of prognosis have been identified and incorporated into the management of patients with acute myeloid leukemia (AML). We hypothesized that rates of molecular testing would be higher in an academic center versus community sites. Rates of molecular testing in AML were higher in an academic center versus community sites in the 5 years following the World Health Organization revised classification of AML. <boxed-text content-type="graphic" id="cam4406-blkfxd-0001" position="anchor" orientation="portrait"><graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgjj256k5f" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></boxed-text></p> </abstract>